Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Zerhouni Moves Up At Sanofi-Aventis To President Of Global R&D

This article was originally published in The Pink Sheet Daily

Executive Summary

Former NIH director drafted by Viehbacher in early 2009 to be his science advisor replaces Cluzel as R&D chief.

You may also be interested in...



Sanofi Says Au Revoir To Viehbacher, But Is It Committing A Faux Pas?

The French pharma's abrupt dismissal of its CEO, citing execution problems with its best-selling drug and issues with management style, has investors wondering whether Chris Viehbacher should have gotten the benefit of the doubt from the company’s board, given his impressive track record.

Sanofi R&D Head Zerhouni Says Global Body For Health Care Is Needed

Drug development and regulation needs to be addressed on a world basis by a supranational entity that could be similar to WTO for trade, a Sanofi exec believes.

Sanofi R&D Head Zerhouni Says Global Body For Health Care Is Needed

Drug development and regulation needs to be addressed on a world basis by a supranational entity that could be similar to WTO for trade, Sanofi exec believes.

Related Content

Topics

UsernamePublicRestriction

Register

LL1133951

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel